Alzheimer Diagnostic Tests – Medical Devices Pipeline Assessment, 2019
- Pages: 431
- Published: December 2019
- Report Code: GDME0835EPD
Alzheimer Diagnostic Tests are blood test that detects the disease before it causes the symptoms. It measures key proteins or protein patterns in blood or spinal fluid (biomarkers). GlobalData's Medical Devices sector report, “Alzheimer Diagnostic Tests – Medical Devices Pipeline Assessment, 2019" provides comprehensive information about the Alzheimer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
The Alzheimer Diagnostic Tests Pipeline Assessment report provides key information and data related to:
Extensive coverage of the Alzheimer Diagnostic Tests under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Alzheimer Diagnostic Tests pipeline products.
Review of Recent Developments in the segment / industry
The Alzheimer Diagnostic Tests Pipeline Assessment report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Alzheimer Diagnostic Tests under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2009 and forecast to 2023
• 4,500+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape
• 56,000+ medical equipment company profiles
• 4,300+ company profiles of medical equipment manufacturers in China and India
• 2,000+ company profiles of medical equipment manufacturers in Japan
• 825+ companies’ revenue splits and market shares
• 1,900+ quarterly and annual medical equipment company financials
• 940+ medical equipment company SWOTs
• 21,500+ pipeline product profiles
• 34,500+ marketed product profiles
• 36,000+ clinical trials
• 36,500+ trial investigators
• 5,400+ reports on companies with products in development
• 33,000+ deals in the medical equipment industry
• 1,300+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.
Scope
– Extensive coverage of the Alzheimer Diagnostic Tests under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Alzheimer Diagnostic Tests and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry
Reasons to buy
The report enables you to:
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Alzheimer Diagnostic Tests under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date
Companies mentioned
AC Immune SA
Acobiom
Acumen Pharmaceuticals Inc
Adlyfe Inc
Admit Therapeutics SL
ADx NeuroSciences NV
Aelan Cell Technologies
Agent Biotech
Albert Ludwigs University of Freiburg
Alere Inc
Alzhyme Pty Ltd
Alzinova AB
Alzohis
Amarantus Bioscience Holdings Inc
Amarantus Diagnostics Inc
Amco International Manufacturing Inc.
Amoneta Diagnostics SAS
Amprion Inc
Applied NeuroSolutions, Inc. (Inactive)
Arkley Biotek LLC
attyloid GmbH
Banyan Biomarkers Inc
BioArctic AB
Bioasis Technologies Inc
Biomedical Development Corp
BioSystems International
Boston University Medical Campus
Brigham and Women's Hospital
C2N Diagnostics LLC
Cassava Sciences Inc
Chronix Biomedical Inc
Cleveland Diagnostics Inc.
Cofactor Genomics Inc
Cognext Diagnostics LLC
Columbia University
CompanDX Ltd
Cymedx
Cytox Ltd
Diadem SRL
DiaGenic ASA
DiamiR LLC
DiaPat GmbH
Durin Technologies, Inc.
Emory University
Eurobio Scientific SA
Florida Institute of Technology
French National Institute of Health and Medical Research
Fujirebio Diagnostics Inc
Fujirebio Europe NV
Ghent University
Grifols SA
IASO BioMed Inc
IBM Research-Australia
ICDD-sas
Inbiomed
Innosense LLC
Innovative Health Diagnostics
Instituto de Estructura de la Materia
Integrated Diagnostics Inc (Inactive)
Janssen Pharmaceutica NV
Johns Hopkins University
Johns Hopkins University School of Medicine
KineMed Inc
King's College London
Laboratory Corp of America Holdings
McGill University Health Center
Medifron DBT Inc
Memory Dx LLC
Meso Scale Diagnostics LLC
Michigan State University
Myriad RBM Inc
NanoSomiX, Inc.
Nanosphere Inc
National University of Singapore
NeoNeuro SAS
Neuro Bio Ltd
NeuroDiagnostics LLC
NeuroQuest Ltd
Neurotrope Bioscience Inc
Newcastle University
Novel Bio-spectrum Technologies Inc (Inactive)
Oligomerix inc
Orasi Medical, Inc. (Inactive)
Oryzon Genomics SA
Peri Rx Inc
Pre Diagnostics AS
Predemtec GmbH
ProMIS Neurosciences Inc
Proplex Technologies Llc
Protagen AG
Proteome Sciences Plc
Proteomics International Laboratories Ltd
Quanterix Corp
Redox Diagnostics LLC
Roche Diagnostics GmbH
Roche Diagnostics International Ltd
Rockefeller University
Ruhr-University Bochum
Scout Diagnostics LLC
Seer Biosciences Inc
Siemens Healthineers AG
SomaLogic Inc
StageZero Life Sciences Ltd
TauRx Pharmaceuticals Ltd
The Florey Institute of Neuroscience and Mental Health
The University of Nottingham
Todos Medical
Trinity College Dublin
True Diagnostics Inc
University of Calgary
University of Chicago
University of Georgia
University of Gottingen
University of Illinois at Chicago
University of Luxembourg
University of Maryland Baltimore
University of Oxford
University of Pittsburgh
University of South Florida
University of Texas Health Science Center at Houston
University of Texas Southwestern Medical Center
Urvogelbio Pvt Ltd
US Biomarkers Inc
vall d hebron institut de Recerca
Vitruvian Biomedical Inc
Washington University in St Louis
Washington University School of Medicine
Zoiray Technologies Inc.
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple report purchases.